Nitec Pharma AG, a Switzerland-based pharmaceutical company focused on the development and commercialization of medicines and treatment solutions for chronic inflammation and pain-related diseases, has signed an agreement with Mundipharma International Corporation Limited, a UK-based company engaged in the research, development, manufacturing, and marketing of pharmaceuticals, under which Mundipharma has obtained an exclusive license for the distribution of Lodotra(TM) in Europe, excluding Germany and Austria which are licensed to Merck KGaA.

Multicare Pharmaceuticals is a branded generic company and commands a premium image with the medical profession with a good position in the Women`s health and Child Care segment.

Endo Pharmaceuticals Holdings Inc. (ENDP), a specialty pharmaceutical company, said it closed the $370 million acquisition of Indevus Pharmaceuticals, Inc. (IDEV).

Dishman Pharma, a Rs 800 crore Ahmedabad based pharma giant, has signed a co-operation and joint API development agreement with Polpharma of Poland. Both companies feel that this partnership will benefit mutually and pave the way for a stronger growth in coming years.